Opinion
4hOpinion
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...
A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging ...
(The Hill) – The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children younger than 5 years old, a move that would add another ...
Novavax, Inc. reported 3Q25 EPS loss & declining revenue, but beat revenue expectations & reaffirmed its FY25 guidance. Read ...
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, ...
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape.
Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...
FLASH2 study Blinded Response Rate to Date Exceeds Trial Estimate PRINCETON, N.J., Nov. 19, 2025 /PRNewswire/ -- ...
The former officials say the agency's plan to revamp how vaccines for flu, Covid and other respiratory viruses are handled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback